Intended use: For the in vitro determination of Activated Partial Thromboplastin Time (APTT) in human citrated plasma on IL Coagulation and ELECTRA systems, to evaluate the intrinsic coagulation pathway, APTT-substitution test and the monitoring of Heparin therapy.
Principle: Buffered reagent which contains phospholipids derived from a synthetic source for optimal platelet-like activity and a nonsettling particulate activator, colloidal silica, for optimal activation of the contact phase of coagulation.
Vials and volumes:
- 5 x 10 mL APTT Reagent (liq)
- 5 x 10 mL Calcium Chloride (liq)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
